On Oct. 20, the US Department of Health and Human Services issued a new Kidney Care National Plan that includes goals to increase market competition, improve transplant options, and emphasize more prevention and innovation.
Diversified by geography and business mix, Fresenius should be able to benefit from ongoing growth in treating ESRD patients worldwide in the long run.
With virtually all of its US service profits coming from commercial insurance, Fresenius' profits could contract in some negative policy scenarios.
|
Metric
|
FME
|
DVA
|
THC
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.03 | 13.79 | 13.92 |
Price/Book Value | 0.81 | — | 4.65 |
Price/Sales | 0.55 | 0.88 | 1.03 |
Price/Cash Flow | 4.07 | 5.44 | 5.47 |
|
Metric
|
FME
|
DVA
|
THC
|
|---|---|---|---|
Quick Ratio | 0.68 | 1.33 | 1.22 |
Current Ratio | 1.07 | 1.47 | 1.41 |
Interest Coverage | 4.76 | 3.47 | 5.71 |
|
Metric
|
FME
|
DVA
|
THC
|
|---|---|---|---|
Return on Assets (Normalized) | 4.50% | 7.71% | 5.60% |
Return on Equity (Normalized) | 10.75% | — | 39.08% |
Return on Invested Capital (Normalized) | 6.66% | 12.79% | 10.73% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Genesis Healthcare Inc Class A
GENNQ
| LOCK|n# | LOCK|^Vr | — | |||
| HCA Healthcare Inc
HCA
| LOCK|nVS>m$ | LOCK|k%Y?? | $99B | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | LOCK|P&M>$ | $29B | |||
| Fresenius SE & Co KGaA Registered Shares
FSNUF
| — | LOCK|PBZc& | $29B | |||
| Tenet Healthcare Corp
THC
| LOCK|#jyTzd | LOCK|vstbH | $22B | |||
| Encompass Health Corp
EHC
| — | LOCK|@$!&r | $12B | |||
| Fresenius Medical Care AG
FMCQF
| — | LOCK|ZqdjC | $11B | |||
| Fresenius Medical Care AG ADR
FMS
| LOCK|@@#lWx | LOCK|@@QqK | $11B | |||
| DaVita Inc
DVA
| LOCK|JZ&WW<X | LOCK|f<Fp | $11B | |||
| Universal Health Services Inc Class B
UHS
| LOCK|bDm&&y | LOCK|Cf@## | $11B |
United States